Director Lawrence Levitt sold 16,000 shares of RadNet Inc on June 10, 2024, at a price of $60.85 per share. This sale leaves Levitt with a total of 174,066 shares of the company. RadNet Inc is known for providing high-quality, cost-effective diagnostic imaging services through its network of outpatient imaging centers, offering services such as MRI, CT, and PET scans.
Over the past year, Lawrence Levitt has only sold shares of RadNet Inc, with no purchases recorded. In total, there have been 8 insider sells and 0 insider buys within the company over the past year. With shares trading at $60.85, RadNet Inc holds a market cap of approximately $4.56 billion and a price-earnings ratio of 205.83, significantly higher than industry and historical medians.
Based on valuation metrics, RadNet Inc is deemed overvalued with a price-to-GF-Value ratio of 2.18, as per GuruFocus calculations. This value considers historical trading multiples, growth adjustments, and future performance estimates provided by Morningstar analysts.
Investors may find interest in insider behaviors like Lawrence Levitt’s sale, which can indicate confidence levels in the company’s current standing and future potential. However, it is crucial to note that this information is general insight and not personalized financial advice. GuruFocus aims to offer data-driven analysis based on historical trends and analyst forecasts, without specific investment recommendations.
It is important to conduct thorough research and consider individual financial circumstances before making investment decisions. GuruFocus does not hold positions in the mentioned stocks and focuses on delivering unbiased analysis for long-term investment strategies. Keep in mind that this analysis may not include recent company announcements or qualitative information.